Procter & Gamble Company (The) $PG Stock Position Cut by Inscription Capital LLC

Key Points

• Inscription Capital cut its Procter & Gamble stake by 65.5% in the third quarter, selling 41,634 shares and retaining 21,961 shares valued at about $3.19 million.
• P&G beat quarterly expectations, reporting adjusted earnings of $2.00 per share and revenue of $23.28 billion, up 4% year over year. The company declared a quarterly dividend of $1.0885 per share.
• Analyst sentiment remains generally positive: 15 analysts rate the stock Buy and 11 Hold, with a consensus target of $170.57. Several company insiders also sold shares recently.

Inscription Capital LLC trimmed its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 65.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,961 shares of the company's stock after selling 41,634 shares during the period. Inscription Capital LLC's holdings in Procter & Gamble were worth $3,190,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new stake in Procter & Gamble in the second quarter valued at approximately $27,862,105,000. State Street Corp increased its position in Procter & Gamble by 1.0% during the 2nd quarter. State Street Corp now owns 102,216,308 shares of the company's stock valued at $14,988,999,000 after purchasing an additional 965,461 shares during the period. Bank of America Corp DE bought a new position in Procter & Gamble during the 2nd quarter worth approximately $3,850,628,000. Bank of New York Mellon Corp bought a new position in Procter & Gamble during the 2nd quarter worth approximately $2,281,505,000. Finally, Dimensional Fund Advisors LP raised its holdings in Procter & Gamble by 2.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company's stock worth $1,704,182,000 after purchasing an additional 300,280 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Sundar Raman sold 38,253 shares of the stock in a transaction on Friday, October 30th. The stock was sold at an average price of $165.00, for a total transaction of $6,311,745.00. Following the completion of the transaction, the chief executive officer owned 47,745 shares in the company, valued at approximately $7,877,925. This represents a 44.48% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Matthew Janzaruk sold 9,479 shares of Procter & Gamble stock in a transaction dated Tuesday, November 3rd. The stock was sold at an average price of $163.00, for a total transaction of $1,545,077.00. Following the completion of the transaction, the chief accounting officer owned 1,271 shares of the company's stock, valued at $207,173. The trade was a 88.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 161,709 shares of company stock worth $26,244,058 in the last three months. Insiders own 0.23% of the company's stock.

Analyst Upgrades and Downgrades

PG has been the subject of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Procter & Gamble from $162.00 to $180.00 and gave the stock an "overweight" rating in a research report on Friday, October 23rd. UBS Group set a $166.00 target price on shares of Procter & Gamble in a report on Friday, October 23rd. TD Cowen upped their price target on shares of Procter & Gamble from $150.00 to $166.00 and gave the company a "hold" rating in a research report on Friday, October 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Procter & Gamble in a research report on Friday, October 23rd. Finally, Citigroup lifted their price objective on Procter & Gamble from $180.00 to $187.00 and gave the stock a "buy" rating in a research report on Friday, October 23rd. Fifteen equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $170.57.

Procter & Gamble Trading Down 0.1%

PG opened at $167.15 on Friday. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $170.52. The firm has a market capitalization of $387.41 billion, a PE ratio of 25.17, a P/E/G ratio of 4.11 and a beta of 0.36. The company's 50-day moving average is $151.56 and its 200 day moving average is $149.34.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion during the quarter, compared to analyst estimates of $22.80 billion. During the same period in the prior year, the firm posted $1.99 EPS. Procter & Gamble's quarterly revenue was up 4.0% compared to the same quarter last year. As a group, research analysts predict that Procter & Gamble Company will post 6.99 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble's payout ratio is 65.51%.

More Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G recently reached a 52-week high as investors favored reliable dividend-paying consumer-staples companies amid political uncertainty. Its latest reported quarter also beat earnings and revenue estimates, with sales up 4% year over year. Article: Dividend stocks reach highs
• Neutral Sentiment: P&G will webcast its November 19 Investor Day, where its leadership team plans to discuss strategy and the company’s long-term transformation. Investors may look for details on growth plans and execution. Article: Investor Day webcast
• Neutral Sentiment: Bernstein maintained a Hold rating on PG, suggesting a cautious view rather than a clear near-term catalyst. Article: Bernstein rating
• Negative Sentiment: CFO Andre Schulten sold 33,624 shares, reducing his direct holding by about 34%. Insider sales can weigh on sentiment, although they do not necessarily signal a change in the company’s outlook. Article: CFO share sale
• Negative Sentiment: A comparison of P&G and Colgate-Palmolive flagged rising oil prices and cautious U.S. shoppers as challenges for margins. The report says the companies’ margins are moving in opposite directions but does not specify which direction applies to P&G. Article: P&G and Colgate-Palmolive comparison

Procter & Gamble Profile

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.